The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope for detection of pancreatic diseases

The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope for detection of pancreatic diseases - The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope for detection of pancreatic diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026627

Enrollment

500

Registered

2017-05-16

Start date

2017-05-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatobiliary diseases

Interventions

Screen pancreas and biliary tract using newly developed endoscope during upper gastrointestinal endoscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of 50 years and upward who undergo upper gastrointestinal endoscopy

Exclusion criteria

Exclusion criteria: Performance status = 3 or 4 Organ failure Screened pancreas within a half year Without the consent Postoperative digestive tract

Design outcomes

Primary

Measure	Time frame
The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope	—

Secondary

Measure	Time frame
The findings acquired from newly developed endoscope	—

Countries

Japan

Contacts

Public ContactDaisuke Uchida

Okayama University Hospital Gastroenterology

d.uchida0309@gmail.com086-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026